NSC 663284 is primarily investigated for its potential in cancer research due to its ability to inhibit specific enzymes involved in cell cycle regulation. It has shown promise in preclinical studies as a cytotoxic agent, targeting rapidly dividing cancer cells and inducing apoptosis. Researchers are exploring its efficacy in combination therapies to enhance the effectiveness of existing cancer treatments. Additionally, its role in modulating cellular pathways makes it a candidate for studying drug resistance mechanisms in various malignancies. Ongoing research aims to optimize its pharmacokinetic properties for potential therapeutic applications.